Intrexon Corporation (XON)

14.19 +0.09 (+0.638%)

IEX Real-Time Price

August 14, 2018 EST.

New York Stock Exchange : Healthcare

Prev Close 14.1

Price Open 14.1

Volume: 719,123

Avg Volume: 1.5M

Market Cap: 1.94B

P/E Ratio -18.19

52 Wk Range 10.255-20.67



XON Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
135.4M
32.02M
26.27
23.65%

2018-07-13
135.4M
31.49M
15.11
23.26%

2018-06-29
135.4M
24.22M
13.44
17.89%

2018-06-15
127.92M
23.95M
28.20
18.72%




XON Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-10
Q1 2018
AMC
-0.24 (4)
-0.17
0.07

2018-05-09
Q1 2018
N/A
-0.24 (4)
0.00
0.00

2018-03-07
Q4 2017
N/A
-0.31 (5)
-0.17
0.14

2018-03-01
Q4 2017
AMC
-0.31 (5)
-0.17
0.14

News

Intrexon preliminary Q2 revenues below consensus; shares down 9% premarket (2018-08-10 09:03 SeekingAlpha)

Intrexon (NYSE: XON ) slips 9% premarket on light volume on the heels of its business update released after the close yesterday. More news on: Intrexon Corp, Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more …

 

Intrexon Corporation (XON) CEO Randal Kirk on Q2 2018 Results - Earnings Call Transcript (2018-08-09 21:45 SeekingAlpha)

Intrexon Corporation (XON) Q2 2018 Earnings Conference Call August 9, 2018 5:30 p.m. ET Executives Steve Harrison - IR Joel Liffmann - SVP, Finance Bob Walsh - SVP, Energy and Fine Chemicals Thomas Bostick - COO Nir Nimrodi - Chief Business Officer Randal Kirk - CEO Anal…

 


Statistics

Shares Outstanding: 136.77M

Top 15 Institution Percent: 79.10

Price To Sales: 11.62

Price To Book: 3.49

Revenue: 46.02M

Gross Profit: 31.00M

Cash: 108.72M

Debt: 8.35M

Return On Assets: -14.09

Return On Equity: -23.59

Profit Margin: -71.11

Price History

Beta: 1.11

50-day Moving Avg: 15.22

200-day Moving Avg: 15.03

YTD Change: 5.35

5-day Change: -7.07

1-month Change: -2.54

3-month Change: -8.16

6-month Change: 5.42

1-year Change: -23.50

Revenue Per Share: 0.00

Revenue Per Employee: 45742.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Intrexon Corporation

Exchange: New York Stock Exchange

Industry: Biotechnology

Sector: Healthcare

Website: http://www.dna.com

Intrexon Corp is a biotechnology company that develops synthetic biology solutions. It designs, builds and regulates gene programs using its proprietary and complementary technologies.